Momentum Event Group will be holding its inaugural "IP Counsel Exchange for Biosimilar Applicants and Sponsors" January 23-24 in New York City.  The effect of the recent Sandoz v. Amgen decision on biosimilar patent litigation strategy is expected to be a main topic of discussion. The conference begins with an interactive working group, where participants can choose…

American Conference Institute will be holding its first-ever "Paragraph IV Disputes Master Symposium" next week, October 3-4, in Chicago.  McAndrews, Held & Malloy Partner Scott McBride will be speaking at the conference on claim construction strategies.  The rest of the agenda is as follows: Identifying patents which may be ripe for challenges of invalidity and…

The Intellectual Property Owners Association will hold its 41st Annual Meeting on September 15-17 in Boston.  The keynote speakers include David Goulden, President and COO, EMC Corporation, and Hon. Kathleen O'Malley, Circuit Judge, U.S. Court of Appeals for the Federal Circuit. In addition, McAndrews, Held & Malloy Shareholder Herbert D. Hart III will be a…

Momentum Event Group will be holding its inaugural "International Congress on Paragraph IV Litigation" September 23-24 in New York City.  The conference will feature a panel discussion with Judge Plager of the Federal Circuit and Judges Salas and Schneider from the District of New Jersey. Here is the complete agenda: Paragraph IV Caselaw Year in…

ACI will be holding its first "Legal and Regulatory Summit on Generic Drugs" in New York City on July 17-18.  The conference co-chairs are Shashank Upadhye, formerly of Apotex, and Kurt Karst of FDA Law Blog. Here's the agenda: The Politics and Policy of the Generic Drug Industry: Understanding the Role of the 113th Congress…

American Conference Institute will be holding its first "Global Patenting Strategy & Practice" conference July 15-16 in New York.  McAndrews, Held & Malloy Partner Scott McBride will be speaking on strategies for protecting trade secrets in multiple jurisdictions. The rest of the agenda includes the following presentations: Understanding the Importance of Developing a Global Strategy…

ACI will be holding its "4th Advanced Forum on Biosimilars" in New York City on June 5-7.  McAndrews, Held & Malloy partner Sandra Frantzen will be speaking on the written description and enablement requirements for biologics patents.  The full agenda includes the following presentations: The Biosimilars Pipeline: Evaluating the Commercial Opportunity and Viability of Follow-On…

ACI will be holding its always-popular "Paragraph IV Disputes" conference in New York City next week, on May 7-8.  This year's conference–the 7th annual–looks better than ever.  The agenda includes the following presentations: Anticipating a Paragraph IV Challenge: New Considerations in Light of AIA and the Patent Cliff Asserting Invalidity or Non-infringement Under Paragraph IV:…

This morning, February 19, 2013, the Supreme Court will hear argument in one of the most important patent cases in recent years-–Bowman v. Monsanto.  The case specifically addresses patent exhaustion in the progeny of soybean seeds.  But the Court’s opinion in this case could impact the protection of some of the most innovative biotechnology inventions…

CPhI will be holding its 2nd annual Pharma IPR India conference in Mumbai on April 10-12.  This was an outstanding conference last year, and it promises to be even better this year. Pharma IPR India 2013 will take place over three days, focusing the first day on pharmaceutical intellectual-property rights in the United States, Canada,…